Downloads

Sorin

Company Intelligence Report

Sorin develops and manufactures medical technologies and therapies for cardiac surgery and for the treatment of cardiac rhythm disorders. At the end of 2008, the company completed a programme of strategic divestitures and concluded a plan to restructure its business portfolio. The divestitures included the sale of its endovascular, coronary stent and renal care businesses. This has allowed the company to better focus on its three core businesses – Cardiac Rhythm Management (CRM), Cardiopulmonary and Heart Valves.

• The CRM business produces pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronisation therapy defibrillators (CRT-Ds), programmers, electrodes, electrophysiology leads and holter monitors.
• The Cardiopulmonary business produces extracorporeal blood circulation systems including oxygenators, heart-lung machines, perfusion tubing sets, autotransfusion systems and disposables, cannulae and endoscopic vessel harvesting (EVH) systems.
• The Heart Valves business offers mechanical heart valves, tissue heart valves, sutureless self-anchoring tissue valves and annuloplasty rings. Sorin is also a distributor of endovascular devices.

Sorin’s recent investments in developing its business include the purchase of equity stakes in Enopace Biomedical (a company developing a neuromodulation system to treat patients with congestive heart failure) and MD Start (a venture capital incubator), as well as the acquisition of a line of arterial and venous cannulae from Endoscopic Technologies Inc and the purchase of Gish Biomedical (a producer of disposable medical devices for cardiovascular surgery).

Sorin’s principal manufacturing and R&D facilities are located in Italy, France, Germany, Canada and the US. The company is present in more than 80 countries throughout the world and serves over 5,000 public and private health institutions.

The Sorin Group was created through the demerger of Snia’s biomedical operations. It was listed separately on the Online Stock Market of the Milan Securities Exchange in January 2004. As of January 2012, its main shareholders included: Bios SpA (19.1%); Tower 6Bis Sarl (6.7%); Banca Monte Dei Paschi di Siena SpA (7.3%); Unipol Assicurazioni SpA (4.6%); GE Capital Equity Holdings (6.4%); and Norges Bank (2.0%).

The {Company name} Medical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D.

Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. Espicom’s Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field.

Key Benefits

• Evaluate competitive threats
• Maximise product and market opportunities
• Identify collaborators and strategic partners
• Understand the operating market environment
• Benchmark your performance against competitors

Coverage Overview

• Key contact information
• Introduction to {Company name} and its current activities
• Summary of its financial performance
• Key recent events in an “at a glance” format

Strategic Focus

• The company’s aims and its areas of focus

Financial Review

• Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
• Table providing in-depth five-year financial analysis
• Employee data, including breakdown by company division and geographic location

Product Overview

• Core product areas, key brands, product approvals and launches
• Identifies the company’s major competitors

Research and Development

• How much has been invested in R&D?
• Where is the research based?
• What alliances and agreements does {Company name} have and with whom?

Manufacturing and Distribution

• Identifying the company’s manufacturing locations
• Sales and marketing facilities

Agreements

• With whom has {Company name} reached agreements and what do they involve?
• Key contracts awarded

Mergers and Acquisitions

Minority Divestments

Litigation

Key Corporate Events

The report was produced as part of Medical Device Companies Analysis (MDCA). For more information on MDCA, click here.